243 related articles for article (PubMed ID: 23839048)
1. FKBPs and the Akt/mTOR pathway.
Hausch F; Kozany C; Theodoropoulou M; Fabian AK
Cell Cycle; 2013 Aug; 12(15):2366-70. PubMed ID: 23839048
[TBL] [Abstract][Full Text] [Related]
2. Large FK506-binding proteins shape the pharmacology of rapamycin.
März AM; Fabian AK; Kozany C; Bracher A; Hausch F
Mol Cell Biol; 2013 Apr; 33(7):1357-67. PubMed ID: 23358420
[TBL] [Abstract][Full Text] [Related]
3. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins.
Schreiber KH; Ortiz D; Academia EC; Anies AC; Liao CY; Kennedy BK
Aging Cell; 2015 Apr; 14(2):265-73. PubMed ID: 25652038
[TBL] [Abstract][Full Text] [Related]
6. Antascomicin B stabilizes FKBP51-Akt1 complexes as a molecular glue.
Schäfer SC; Voll AM; Bracher A; Ley SV; Hausch F
Bioorg Med Chem Lett; 2024 May; 104():129728. PubMed ID: 38582133
[TBL] [Abstract][Full Text] [Related]
7. FK506 binding proteins as targets in anticancer therapy.
Romano S; Di Pace A; Sorrentino A; Bisogni R; Sivero L; Romano MF
Anticancer Agents Med Chem; 2010 Nov; 10(9):651-6. PubMed ID: 21182472
[TBL] [Abstract][Full Text] [Related]
8. FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention.
Annett S; Moore G; Robson T
Pharmacol Ther; 2020 Nov; 215():107623. PubMed ID: 32622856
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
[TBL] [Abstract][Full Text] [Related]
11. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway.
Lee KW; Yook JY; Son MY; Kim MJ; Koo DB; Han YM; Cho YS
Stem Cells Dev; 2010 Apr; 19(4):557-68. PubMed ID: 19642865
[TBL] [Abstract][Full Text] [Related]
13. Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor.
Zou CY; Smith KD; Zhu QS; Liu J; McCutcheon IE; Slopis JM; Meric-Bernstam F; Peng Z; Bornmann WG; Mills GB; Lazar AJ; Pollock RE; Lev D
Mol Cancer Ther; 2009 May; 8(5):1157-68. PubMed ID: 19417153
[TBL] [Abstract][Full Text] [Related]
14. In smooth muscle, FK506-binding protein modulates IP3 receptor-evoked Ca2+ release by mTOR and calcineurin.
MacMillan D; Currie S; Bradley KN; Muir TC; McCarron JG
J Cell Sci; 2005 Dec; 118(Pt 23):5443-51. PubMed ID: 16278292
[TBL] [Abstract][Full Text] [Related]
15. FKBP family proteins: immunophilins with versatile biological functions.
Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
[TBL] [Abstract][Full Text] [Related]
16. LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway.
Chen Z; Yang L; Liu Y; Tang A; Li X; Zhang J; Yang Z
Mol Cell Biochem; 2014 Jan; 385(1-2):169-77. PubMed ID: 24072614
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin restrains platelet procoagulant responses via FKBP-mediated protection of mitochondrial integrity.
Śledź KM; Moore SF; Durrant TN; Blair TA; Hunter RW; Hers I
Biochem Pharmacol; 2020 Jul; 177():113975. PubMed ID: 32298692
[TBL] [Abstract][Full Text] [Related]
18. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB.
Varma S; Khandelwal RL
Biochim Biophys Acta; 2007 Jan; 1770(1):71-8. PubMed ID: 16952420
[TBL] [Abstract][Full Text] [Related]
19. Neural roles of immunophilins and their ligands.
Sabatini DM; Lai MM; Snyder SH
Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011
[TBL] [Abstract][Full Text] [Related]
20. Differential Phosphatidylinositol-3-Kinase-Akt-mTOR Activation by Semliki Forest and Chikungunya Viruses Is Dependent on nsP3 and Connected to Replication Complex Internalization.
Thaa B; Biasiotto R; Eng K; Neuvonen M; Götte B; Rheinemann L; Mutso M; Utt A; Varghese F; Balistreri G; Merits A; Ahola T; McInerney GM
J Virol; 2015 Nov; 89(22):11420-37. PubMed ID: 26339054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
